Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats w

来源 :国际肝胆胰疾病杂志:英文版 | 被引量 : 0次 | 上传用户:myrost
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND: The pathogenesis and progression of acute liver failure (ALF) are closely associated with intestinal endotoxemia because of the high permeability of the intestinal wall. Treatment with ethyl pyruvate (EP) has been shown to protect liver failur
其他文献
【正】Introduction Liver failure is defined as hepatocellular dysfunction manifested by severe synthetic and metabolic disturbance with extremely high mortality
期刊
BACKGROUND:Recurrence of hepatocellular carcinoma(HCC) after liver transplantation(LT) remains one of the most common causes of poor long-term survival.However,
BACKGROUND: Liver surgery has gone through the phases of wedge liver resection, regular resection of hepatic lobes, irregular and local resection, extracorporea
Liver transplantation for autoimmune hepatitis(AIH) is usually successful with excellent long-term outcomes,but primary disease may recur. The recurrence of AIH
期刊
<正>To the Editor:We read with great interest the recent paper by Baran and colleagues,[1]published in the journal of Hepatobiliary Pancreatic Diseases Internat
期刊
BACKGROUND: Laparoscopic pancreaticoduodenectomy(LPD)is a safe procedure. Oncological safety of LPD is still a matter for debate. This study aimed to compare th
BACKGROUND: Autoimmune pancreatitis (AIP) is increasingly recognized as a unique subtype of pancreatitis. This study aimed to analyze the diagnosis and treatmen
BACKGROUND: The prognostic factors related to lymph node involvement [lymph node status, the number of positive lymph nodes, lymph node ratio (LNR)] and the num
Domino liver transplantation(LT), using livers from familial amyloidotic polyneuropathy(FAP) patients, is a well described technique useful to expand donor pool
BACKGROUND:Adipose-derived stem cells(ADSCs) are particularly attractive in future clinical applications of stem cell-based therapy for acute-on-chronic liver f